Next-Generation Antibody Therapies: World Industry and Market 2014-2024

Next-Generation Antibody Therapies:Next-Generation Antibody Therapies: World Industry and Market 2014-2024 PR Newswire LONDON, March 5, 2014 Antibody technology - discover R&D, business analysis, and revenue forecasts What's the future of technologies harnessing therapeutic antibodies? Now you can get technological and business predictions. Stay ahead for data, helping your authority. There you explore developmental trends, sales results, opportunities, and revenue forecasts. Visiongain's new report shows you what's possible for monoclonal antibodies (mAbs) and other immunotechnology for pharmaceuticals. Avoid missing out. Instead find progress in that medical industry and market, discovering the expected progress and gains. Read on to explore those drugs, seeing how high revenues can go. Forecasts and other information showing lucrative biopharmaceutical possibilities The updated study gives you sales predictions to 2024 at overall world, submarket, product, and regional level. For those treatments - antibodies and variants - you investigate where money lies. Hear what's possible. Also avoid struggles to find information. Besides revenue forecasting, our new work shows historical performance, recent results, growth rates, and market shares. There you also gain feel for developments (R&D) in those medicines. So discover 74 tables, 58 charts, and three interviews with authorities in that industry, helping your research, analyses, and decisions.